ANI Pharmaceuticals is building a leading Rare Disease company focused on Serving Patients, Improving Lives

RECENT NEWS

ANI Pharmaceuticals to Present at Upcoming December Investor Conference

2026-11-19

READ MORE >

ANI Pharmaceuticals Reports Third Quarter 2026 Financial Results

2026-11-05

READ MORE >

NASDAQ - ANIP

$68.75

-0.38 (-0.55%)

Pricing delayed by 20 minutes
Last updated 2026-11-20 15:24:00